A

Acumen Pharmaceuticals (ABOS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.

  • USD4.07
  • USD4.13
  • USD3.86
  • USD10.97
  • -23.90%
  • --
  • 44.47k
  • 97.54k
  • 160M
  • 3.02
  • -13.90%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.